USFDA has removed partial lifting of import alert on APIs manufacturing facility at Ratlam: Ipca Laboratories

In a regulatory filing Ipca Laboratories said, the US Food and Drug Administration (USFDA) has informed the company that the "shortage implications for chloroquine phosphate API has changed and chloroquine phosphate drug product is no longer in shortage and therefore, no shipment of API chloroquine phosphate will be excluded from the import alert."

from Moneycontrol Business News https://ift.tt/2ByLDiM